Peripheral blood LAG + CD8 + T cells are more commonly identified in immunotherapy-treated patients with cancer who have less favorable outcomes.
No takes yet. Share an insight, caveat, or question.
Shen et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: